Crossmark

ASO Author Reflections: Preceding Systemic Chemotherapy Might Provide Better Prognosis for Pancreatic Ductal Adenocarcinoma with Positive Peritoneal Cytology

Crossref DOI link: https://doi.org/10.1245/s10434-021-09755-9

Published Online: 2021-02-25

Published Print: 2021-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ariake, Kyohei https://orcid.org/0000-0002-7261-4349
Mizuma, Masamichi

Motoi, Fuyuhiko

Unno, Michiaki
License Information

Text and Data Mining valid from 2021-02-25

Version of Record valid from 2021-02-25
More Information

Article History

Received: 8 February 2021

Accepted: 8 February 2021

First Online: 25 February 2021

Disclosure

: Fuyuhiko Motoi received a research Grant from Taiho Pharmaceutical and Chugai Pharmaceutical. Michiaki Unno received a research Grant from Taiho Pharmaceutical. This work was also funded by a research Grant from Yakult Honsha and honoraria from Taiho Pharmaceutical.

Document is current

Any future updates will be listed below